Release Date: 16/10/12 14:07 Summary: Corporate Presentation October 2012 Price Sensitive: No Download Document 4.32MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%